Yu et al. [9] found that the expression levels of CASC2 are low in the pancreatic cancer tissues and cancer cells and that CASC2 expression is closely related to overall patient survival, indicating that high expression of CASC2 is associated with a better prognosis in patients with pancreatic cancer. This evidence concerns the gene CASC2 and pancreatic neoplasm.